Healthcare - Biotechnology - NASDAQ - US
$ 1.34
-2.9 %
$ 1.93 M
Market Cap
-0.15
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
--1257.13%
Net Income
Estimate
--6401.51%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Salarius Pharmaceuticals, Inc.
SLRX has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart SLRX
EBIT FORECAST
EBIT Forecast Chart SLRX
NET INCOME FORECAST
Net Income Chart SLRX